| 000 | 01535 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516234423.0 | ||
| 264 | 0 | _c20151102 | |
| 008 | 201511s 0 0 eng d | ||
| 022 | _a1476-5381 | ||
| 024 | 7 |
_a10.1111/bph.12945 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCobret, L | |
| 245 | 0 | 0 |
_aTargeting the cis-dimerization of LINGO-1 with low MW compounds affects its downstream signalling. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cFeb 2015 |
||
| 300 |
_a841-56 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDimerization |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 | _aMolecular Weight |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPhenoxybenzamine _xchemistry |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aDe Tauzia, M L | |
| 700 | 1 | _aFerent, J | |
| 700 | 1 | _aTraiffort, E | |
| 700 | 1 | _aHénaoui, I | |
| 700 | 1 | _aGodin, F | |
| 700 | 1 | _aKellenberger, E | |
| 700 | 1 | _aRognan, D | |
| 700 | 1 | _aPantel, J | |
| 700 | 1 | _aBénédetti, H | |
| 700 | 1 | _aMorisset-Lopez, S | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 172 _gno. 3 _gp. 841-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bph.12945 _zAvailable from publisher's website |
| 999 |
_c24224111 _d24224111 |
||